Zami Aberman, CEO & Chairman at PLURISTEM THERAPEUTICS INC (PSTI), bought 5,000 shares at $1.33 ($7K) on 2016-02-22, disclosed to the SEC on 2016-02-24.
Open-market purchase of $7k PSTI by CEO & Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| PSTI | BUY | 2019-04-08 | $100K | — | Filing → |
| PSTI | BUY | 2016-02-17 | $16K | — | Filing → |
| PSTI | BUY | 2016-02-16 | $25K | — | Filing → |